Dr. Miles: "Teaching the Immune System to Fight Back Against Cancer"
Dr. Brett Miles, the lead investigator on the Advaxis head and neck cancer trial at Mount Sinai said their early data looks promising and they have seen some immune response to the tumors. "The exciting thing about immunotherapy is that traditional therapies like radiation treat at the point of time, but they don't offer any long-lasting benefits for these types of cancers. Immunotherapy has a long-lasting benefit because the idea is to make sure the patient's immune system is aware of these potentially circulating cells." Read more
Mount Sinai Surgeon Performs Radiofrequency Ablation for Thyroid Nodules
Aug 27, 2019 View All Press Releases